Anagram
8 known investors
Anagram runs the full insurance revenue cycle for eye care practices, handling eligibility and benefits checks, claim scrubbing and submission, denial management, and payment posting and reconciliation across both vision and medical insurance. The platform is used by independent eye care providers to manage in- and out-of-network insurance billing.
Investors · 8
GreatPoint VenturesSan Francisco · $250K – $20M
Healthy VenturesMill Valley · $1M – $3M
ManchesterStory Group, LLCWest Des Moines
Blackstone Life Sciencesreported · 2 sourcesNew York · $20M – $60M
KEC VenturesreportedNew York
Kickstartreported · 2 sourcesSalt Lake City · $250K – $3M
NextView Venturesreported · 2 sourcesSan Francisco · $250K – $4M
Waterline VenturesreportedCambridge
Funding
SEC filings, press & company announcements- Undisclosed amountSeries AFeb 2025 · 2 sourcesSource ↗
- Undisclosed amountpre-seedFeb 2024
Kickstart Fund (lead), NextView Ventures (lead)
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Anagram do?
- Anagram runs the full insurance revenue cycle for eye care practices, handling eligibility and benefits checks, claim scrubbing and submission, denial management, and payment posting and reconciliation across both vision and medical insurance. The platform is used by independent eye care providers to manage in- and out-of-network insurance billing.
- Who are Anagram's investors?
- Anagram's investors include GreatPoint Ventures, Healthy Ventures, ManchesterStory Group, LLC, Blackstone Life Sciences, KEC Ventures, Kickstart, NextView Ventures, Waterline Ventures.